Endometrial cancer is significantly influenced by PTEN, and extensive molecular studies have consistently identified PTEN inactivation as the primary cause of endometrioid carcinoma, which is particularly true for individuals with PTEN-related disorders. The gene discussed is PTEN; the disease is endometrioid adenocarcinoma.